All In MedTech

Device Trial Radar · NCT05923827

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 189 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

189

Actual

Start

Sep 11, 2023

Primary completion

Aug 16, 2024

Study completion Feb 12, 2026

Sponsor

Lead sponsor
Insulet CorporationPublic (PODD)
Sponsor type
Industry
First posted
Jun 28, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 4 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous glucose monitor compared to Multiple Daily Injections (MDI) along with the FreeStyle Libre 2 continuous glucose monitor in children and adults with type 1 diabetes.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • Omnipod 5 SystemDevice

    The Omnipod 5 system is a tubeless patch pump that receives glucose values and trend data from the glucose sensor every 5 minutes, automatically calculates insulin dose, and sends delivery commands to the Pod for the delivery of insulin.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in HbA1c (%)Time frame: Comparing intervention group with control group during the 13-week study phase

Locations

19 sites in 3 countries. Site status is shown where the registry gives one.

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • Centre Hospitalier Universitaire Côte de Nacre

    Caen, France

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.